Find here all the news from the CBM and beyond
Filtrer par
Enter in CBM labs !
Discover some experiences
SFNano Webinar - March 31st, 2021
Webinar on mRNA vaccines
Webinar "RMN solide in vivo pour l'étude de membranes biologiques" - March 19, 2021
Dr Dror WARSCHAWSKI,Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, Paris
J.-M. Bonmatin co-author of a letter in Science
J.-M. Bonmatin and six co-authors have just published a letter in the January 8, 2021 issue of Science magazine, entitled "Stay true to integrated pest management"
Decline in insect populations
J.-M. Bonmatin, co-author of an article in Science (December 18, 2020) questions the conclusions of a study on the decline of insects published in April
Towards new imaging markers for in vivo detection of pathologies such as Alzheimer's or diabetes
Researchers from CBM and LCC (Toulouse) have designed a new probe to detect amyloid deposits biomarkers of these diseases
Neonicotinoids
The link between neoniconitoides and contamination of soils and populations highlighted
Detection of amyloid peptides: biomarkers for Alzheimer’s Disease and Diabetes
The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
RNA Remodeling Proteins, Methods and Protocols
The second edition, edited by Marc Boudvillain, has just been published
Biotechnocentre Letter issue 73, 2020 October
October 23rd, 2020 - External seminar externe Dr Béatrice Heurtault, Laboratoire de Conception et Application de Molécules Bioactives, Illkirch
.
Metabolomic Nuclear Magnetic Resonance Studies at Presymptomatic and Symptomatic Stages of Huntington’s Disease on a Drosophila Model
NMR studies show 16 metabolites discriminate symptomatic from presymptomatic stages in a Drosophila model of Huntington's disease. Potential biomarkers of the human disease?
Targeting the LINGO-1 receptor and its hetero-complexes: new therapeutic perspectives for the treatment of demyelinating and neurodegenerative diseases
CBM researchers in collaboration with INSERM U1195 (Kremlin-Bicêtre) have shown that the LINGO-1 receptor can form homo- and hetero-complexes with its homologs LINGO-2, LINGO-3 and LINGO-4 in the brain thus opening the way to new strategies to modulate their activity.
October 9th, 2020 - External seminar Dr Julien Robert-Paganin, Institut Curie, Paris
Pure and stable white light
Researchers from CBM and the University of Michigan used a lanthanide, dysprosium, to generate pure white light with no variation in hue.